We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 953 results
  1. A Cholecystokinin Analogue Ameliorates Cognitive Deficits and Regulates Mitochondrial Dynamics via the AMPK/Drp1 Pathway in APP/PS1 Mice

    Background

    There are no drugs on the market that can reverse or slow Alzheimer’s disease (AD) progression. A protease-resistant Cholecystokinin (CCK)...

    L. Hao, M. Shi, ... Zijuan Zhang in The Journal of Prevention of Alzheimer's Disease
    Article 08 January 2024
  2. Banxia **exin Decoction Alleviated Cerebral Glucose Metabolism Disorder by Regulating Intestinal Microbiota in APP/PS1 Mice

    Objective

    To identify whether Banxia **exin Decoction (BXD) alleviates cerebral glucose metabolism disorder by intestinal microbiota regulation in...

    Chen-yan Gao, Gao-feng Qin, ... Peng-wen Wang in Chinese Journal of Integrative Medicine
    Article 21 November 2023
  3. VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration

    Activation of innate immunity in the brain is a prominent feature of Alzheimer’s disease (AD). The present study investigated the regulation of...

    Fangfang Qi, Zejie Zuo, ... Kaihua Guo in Molecular Psychiatry
    Article Open access 06 June 2023
  4. Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer’s disease

    Although there are indications of a trend towards less severe acute respiratory symptoms and a decline in overall lethality from the novel...

    Jiang Chen, Junsheng Chen, ... Jun Tan in Translational Psychiatry
    Article Open access 16 December 2023
  5. [18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice

    Background

    Oxidative stress is implicated in the pathogenesis of the most common neurodegenerative diseases, such as Alzheimer’s disease (AD)....

    Chia-Ju Hsieh, Catherine Hou, ... Robert H. Mach in EJNMMI Research
    Article Open access 27 July 2022
  6. NREM sleep loss increases neurofilament light chain levels in APP/PS1 and C57BL/6 J mice

    Purpose

    Sleep disturbances exacerbate the progression of Alzheimer’s disease (AD), but disturbances of non-rapid eye movement (NREM) sleep and rapid...

    Shunjie Liu, Zhiying Zhang, ... Zhong Li in Sleep and Breathing
    Article 07 October 2022
  7. Tetrahydroxy Stilbene Glucoside Ameliorates Cognitive Impairments and Pathology in APP/PS1 Transgenic Mice

    Cognitive impairment is the main clinical manifestation of Alzheimer’s disease (AD), and amyloid-β (Aβ) deposition and senile plaques are the...

    Dan Gao, Chen Chen, ... Lan Zhang in Current Medical Science
    Article 20 April 2021
  8. Active constituent of Polygala tenuifolia attenuates cognitive deficits by rescuing hippocampal neurogenesis in APP/PS1 transgenic mice

    Background

    Alzheimer’s disease (AD) is the most common dementia worldwide, and there is still no satisfactory drug or therapeutic strategy. Polygala...

    **ao-feng Wang, Hong-he **ao, ... **ao-le Hu in BMC Complementary Medicine and Therapies
    Article Open access 25 October 2021
  9. Cerebralcare Granule® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions

    Background

    Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by memory deficits and cognitive decline. Current drugs...

    Ou Qiao, **nyu Zhang, ... Wenyuan Gao in Chinese Medicine
    Article Open access 28 June 2021
  10. Suan-Zao-Ren Decoction ameliorates synaptic plasticity through inhibition of the Aβ deposition and JAK2/STAT3 signaling pathway in AD model of APP/PS1 transgenic mice

    Background

    Suan-Zao-Ren Decoction (SZRD) has been widely used to treat neurological illnesses, including dementia, insomnia and depression. However,...

    Qing-Hua Long, Yong-Gui Wu, ... ** Wang in Chinese Medicine
    Article Open access 21 January 2021
  11. ALDH2 contributes to melatonin-induced protection against APP/PS1 mutation-prompted cardiac anomalies through cGAS-STING-TBK1-mediated regulation of mitophagy

    Ample clinical evidence suggests a high incidence of cardiovascular events in Alzheimer’s disease (AD), although neither precise etiology nor...

    Shuyi Wang, Lin Wang, ... Jun Ren in Signal Transduction and Targeted Therapy
    Article Open access 24 July 2020
  12. Chronic intermittent hypoxia induces cognitive impairment in Alzheimer’s disease mouse model via postsynaptic mechanisms

    Purpose

    Obstructive sleep apnea (OSA) is highly comorbid with Alzheimer’s disease (AD) and may represent a risk factor for inducing or accelerating...

    Juan Li, **gying Ye in Sleep and Breathing
    Article 24 January 2024
  13. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice

    Alzheimer’s disease (AD) shows cognitive impairments in clinic, which is multifactorial with different etiopathogenic mechanisms such as Aβ...

    Jian Bao, Wei Liu, ... **-ji Shu in Current Medical Science
    Article 01 February 2020
  14. Kai-**n-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway

    Background

    Kai-**n-San (KXS) has been reported to have a good curative impact on dementia. The purpose of the study was to determine whether KXS might...

    ShiJie Su, Gongcan Chen, ... Qi Wang in Chinese Medicine
    Article Open access 14 March 2023
  15. Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer’s disease-type pathology and cognitive deficits in APP/PS1 mice

    Alzheimer’s disease (AD) is the most common cause of age-related dementia and is currently incurable. The failures of current clinical trials and the...

    Jun Wang, Bin-Lu Sun, ... Yan-Jiang Wang in Translational Psychiatry
    Article Open access 13 July 2020
  16. Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease

    Early onset familial Alzheimer’s disease (FAD) with APP, PS1/2 (presenilins) mutation accounts for only a small portion of AD cases, and most are...

    Zhengjiang Qian, ZhiHao Wang, ... Keqiang Ye in Molecular Psychiatry
    Article Open access 24 April 2024
  17. Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA

    Background

    P2X7 receptor has emerged as a potentially superior PET imaging marker to TSPO, the gold standard for imaging glial reactivity. [ 11 C]SMW139...

    Obada M. Alzghool, Richard Aarnio, ... Merja Haaparanta-Solin in EJNMMI Research
    Article Open access 06 March 2024
Did you find what you were looking for? Share feedback.